H. Lundbeck A/S (CPH:HLUN.B)
44.78
+0.28 (0.63%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Rexulti | 5.20B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Rexulti Growth | 14.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brintellix/Trintellix | 4.85B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Brintellix/Trintellix Growth | 12.10% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abilify Long-acting Injectable Franchise | 3.50B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Abilify Long-acting Injectable Franchise Growth | 9.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Pharmaceuticals | 3.18B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Pharmaceuticals Growth | -1.97% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vyepti | 2.91B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Vyepti Growth | 71.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cipralex/Lexapro | 2.05B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cipralex/Lexapro Growth | -4.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items | 366.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items Growth | 11.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items | -52.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items Growth | -137.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sabril | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Sabril Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Onfi | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Onfi Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Northera | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Northera Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items | 366.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items Growth | 11.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items | -52.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items Growth | -137.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2005 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2005 - 2019 |
| Reconciling Items | 366.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items Growth | 11.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items | -52.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items Growth | -137.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States | 11.33B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| United States Growth | 15.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International | 5.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| International Growth | 4.57% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe | 5.13B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Europe Growth | 11.21% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items | 366.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Reconciling Items Growth | 11.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark | 15.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Denmark Growth | 7.14% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items | -52.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Exceptional Items Growth | -137.96% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| North America Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|